Business Segments Otsuka Corporation

Equities

Market Closed - Japan Exchange Other stock markets 06:30:00 16/01/2026 GMT			5-day change	1st Jan Change
3,225.00 ^JPY	+1.22%		+0.91%	-0.22%

01-12	Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026	CI
11-25	US FDA approves Otsuka's drug for a type of kidney disease	RE

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (JPY)

Fiscal Period: December	2020	2021	2022	2023	2024
Information Technology (IT) Consulting
System Integration Business	527B	524B	542B	630B	732B
Total Assets	172B	160B	194B	201B	304B
CAPEX	-4.49B	-5.54B	-4.11B	-	-
D&A	3.52B	3.78B	4.45B	4.24B	4.71B
Operating Income	50.96B	50.55B	51.79B	57.58B	65.9B
Technology Hardware and Equipment Distribution
Service and Support Business	310B	329B	320B	348B	377B
Total Assets	117B	125B	127B	129B	135B
CAPEX	-3.81B	-5.08B	-2.9B	-	-
D&A	3.23B	3.37B	3.21B	3.08B	3.18B
Operating Income	14.44B	14.23B	12.52B	15.84B	20.38B
Unallocated Adjustments	-1.05B	-802M	-623M	-706M	-826M
Total Assets	182B	202B	202B	232B	234B
CAPEX	-566M	-264M	-76M	-	-
D&A	845M	831M	629M	619M	541M
Operating Income	-9.1B	-8.96B	-9.54B	-10.46B	-11.92B
Motor Vehicle Repair and Services
Other	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (JPY)

Fiscal Period: December	2020	2021	2022	2023	2024
Japan	836B	852B	861B	977B	1,108B
Total Assets	471B	486B	523B	562B	674B
Interest Expense	-44M	-44M	-43M	-41M	-55M
Income Tax Expense	17.77B	17.72B	16B	16.8B	19.61B
D&A	7.6B	7.98B	8.29B	7.93B	8.43B
CAPEX	-8.86B	-10.88B	-7.08B	-3.99B	-3.22B
Gross Profit	174B	177B	184B	204B	224B
Net Income	39.31B	39.93B	40.02B	47.45B	53.48B
EBT	57.58B	58.19B	56.51B	64.89B	73.84B
Operating Income	56.31B	55.83B	54.77B	62.96B	74.36B